安大略省研究人员在伦敦发现生物标志,可以预测前列腺癌治疗反应,促成个性化疗法和更好的结果。 London, Ontario researchers found biomarkers that predict prostate cancer treatment response, enabling personalized therapy and better outcomes.

安大略省伦敦的研究人员开发了一种新方法,以更好地预测前列腺癌患者将如何应对治疗,从而有可能改善个性化护理。 Researchers in London, Ontario, have developed a new method to better predict how prostate cancer patients will respond to treatment, potentially improving personalized care. 他们的研究在一份主要医学期刊上发表,确定了与抗药性治疗相关的具体生物标志,使医生能够更有效地定制治疗方法。 Their study, published in a leading medical journal, identifies specific biomarkers linked to treatment resistance, allowing doctors to tailor therapies more effectively. 研究结果可能导致对治疗计划提前进行调整,减少不必要的副作用,并改进结果。 The findings could lead to earlier adjustments in treatment plans, reducing unnecessary side effects and improving outcomes. 研究小组目前正在与临床医生合作,在临床环境中实施这一方法。 The research team is now working with clinicians to implement the approach in clinical settings.